Cita APA

Romero-Pérez, I., Díaz-Rodríguez, E., Sánchez-Díaz, L., Montero, J. C., & Pandiella, A. (2024). Peptidylarginine deiminase 3 modulates response to neratinib in HER2 positive breast cancer.

Citación estilo Chicago

Romero-Pérez, Inés, Elena Díaz-Rodríguez, Laura Sánchez-Díaz, Juan Carlos Montero, y Atanasio Pandiella. Peptidylarginine Deiminase 3 Modulates Response to Neratinib in HER2 Positive Breast Cancer. 2024.

Cita MLA

Romero-Pérez, Inés, et al. Peptidylarginine Deiminase 3 Modulates Response to Neratinib in HER2 Positive Breast Cancer. 2024.